How should the war on drugs be fought? Everyone seems to agree that the United States ought to use a combination of several different approaches to combat the destructive effects of illegal drug use. Yet there is a remarkable paucity of data and research information that policy makers require if they are to create a useful, realistic policy package-details about drug use, drug market economics, and perhaps most importantly the impact of drug enforcement activities.
Informing America's Policy on Illegal Drugs recommends ways to close these gaps in our understanding-by obtaining the necessary data on drug prices and consumption (quantity in addition to frequency); upgrading federal management of drug statistics; and improving our evaluation of prevention, interdiction, enforcement, and treatment efforts.
The committee reviews what we do and do not know about illegal drugs and how data are assembled and used by federal agencies. The book explores the data and research information needed to support strong drug policy analysis, describes the best methods to use, explains how to avoid misleading conclusions, and outlines strategies for increasing access to data. Informing America's Policy on Illegal Drugs also discusses how researchers can incorporate randomization into studies of drug treatment and how state and local agencies can compare alternative approaches to drug enforcement.
Charting a course toward a better-informed illegal drugs policy, this book will be important to federal and state policy makers, regulators, researchers, program administrators, enforcement officials, journalists, and advocates concerned about illegal drug use.
Table of Contents
|2 Determinants and Consequences of Drug Use||37-74|
|3 Data Needs for Monitoring Drug Problems||75-123|
|4 Drug Data Organization||124-136|
|5 Supply-Reduction Policy||137-186|
|6 Sanctions against Users of Illegal Drugs||187-207|
|7 Preventing Drug Use||208-240|
|8 Treatment of Drug Users||241-270|
|9 Final Thoughts: Unfinished Business||271-280|
|Appendix A: Characteristics of STRIDE Cocaine Data||281-295|
|Appendix B: Data Sources||296-318|
|Appendix C: Phase I Report Executive Summary||319-320|
|Appendix D: How Do Response Problems Affect Survey Measurement of Trends in Drug Use?||321-348|
|Appendix E: Linking Treatment to Punishment: An Evaluation of Drug Treatment in the Criminal Justice System||349-381|
|Appendix F: Biographical Sketches||382-388|
Find relevant information like your own rough draft from among the thousands of reports available for free at NAP.edu. Copy and paste up to 8 pages of content—whether from your own draft or an outside article—and Reference Finder will recommend NAP publications related to your text.
View Reference Finder
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, please click here to view more information.
Loading stats for Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us...